These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18198633)

  • 21. Low molecular weight heparins: the future of thromboembolic therapy.
    Dobbin KR
    Nurse Pract; 1998 Mar; 23(3):98,101-4,106-7. PubMed ID: 9560832
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-molecular-weight heparins.
    Weitz JI
    N Engl J Med; 1997 Sep; 337(10):688-98. PubMed ID: 9278467
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments.
    Davenport A
    Nephrology (Carlton); 2009 Aug; 14(5):455-61. PubMed ID: 19674314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin: from animal organ extract to designer drug.
    Middeldorp S
    Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Present opinions concerning the administration of low molecular weight heparins in hemodialysis patients].
    Drozdz M; Kowalczyk-Michałek M; Kraśniak A; Sułowicz W
    Przegl Lek; 2005; 62(4):257-9. PubMed ID: 16229247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
    Duhl AJ
    J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New options in the prevention and treatment of thromboembolic disease: low-molecular-weight heparins].
    Sureda A; García Frade LJ; Navarro JL
    Sangre (Barc); 1990 Oct; 35(5):389-96. PubMed ID: 1963241
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 32. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
    Bick RL; Frenkel EP; Walenga J; Fareed J; Hoppensteadt DA
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):1-51, v. PubMed ID: 15639107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is unfractionated heparin equivalent to low-molecular-weight heparin for venous thromboembolism?
    Graber MA; Dachs R; Darby-Stewart A
    Am Fam Physician; 2008 Jun; 77(11):1492-3. PubMed ID: 18581828
    [No Abstract]   [Full Text] [Related]  

  • 34. Monitoring and management of heparin-induced thrombocytopenia.
    Rogers B; Little Nj; Jones C
    Br J Hosp Med (Lond); 2009 Nov; 70(11):630-3. PubMed ID: 20081589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism.
    Prandoni P
    J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of thrombosis in traumatology].
    van Hensbroek PB; Haverlag R; Ponsen KJ; Levi M; Goslings JC
    Ned Tijdschr Geneeskd; 2007 Jan; 151(4):234-9. PubMed ID: 17323878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin therapy in pediatric patients.
    Sutor AH; Massicotte P; Leaker M; Andrew M
    Semin Thromb Hemost; 1997; 23(3):303-19. PubMed ID: 9255911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of low-molecular weight heparin during hemodialysis].
    Kalinowski M; Pawlak K; Myśliwiec M; Popławski A
    Pol Merkur Lekarski; 1997 Jan; 2(9):208-10. PubMed ID: 10907031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
    MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study of low molecular weight heparin and unfractionated heparin in patients on maintenance hemodialysis].
    Noguchi M; Izumi K; Deguchi K; Endoh T; Tsuda M; Shirakawa S
    Rinsho Byori; 1990 Jul; Suppl 86():177-83. PubMed ID: 2172594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.